Shelter Pharma Ltd — Dividend/Bonus, 02-09-2025: Corp. Action

The company's Board has approved holding its 18th Annual General Meeting for the financial year ended March 31, 2025. The Board approved a final dividend of 3.5%, equivalent to Rs. 0.35 per equity share of Rs. 10 each, pending shareholder approval. For dividend entitlement and e-voting, a cutoff date has been set, and the register of members will temporarily close. Additionally, M/s Alvi & Associates Chartered Accountants have been approved as the new Statutory Auditors for a five-year term, succeeding the resigning auditor, M/s Mendajiwala & Co. This appointment is also subject to shareholder approval.